Annals of Pharmacotherapy Journal Issues Research Articles in July 2022 Edition
May 16, 2022
May 16, 2022
THOUSAND OAKS, California, May 16 -- Annals of Pharmacotherapy, a peer-reviewed journal that says it advances pharmacotherapy for the treatment and prevention of illnesses, published research articles on the following topics in its July 2022 edition:
Research Reports:
* Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia
* Hemodynamic Effects of Ketamine Compared With Propofol or Dexmedetomidine as Continuous ICU Se . . .
Research Reports:
* Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia
* Hemodynamic Effects of Ketamine Compared With Propofol or Dexmedetomidine as Continuous ICU Se . . .